You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 297 No. 14, April 11, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Informatics/ Internet in Medicine
 •Informatics, Other
 •Quality of Care
 •Evidence-Based Medicine
 •Diet
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Folic Acid Supplementation and Cardiovascular Diseases—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: In response to Dr Mahid and colleagues, although we did not have access to EMBASE, we did conduct bibliographic searches of review articles and included abstracts from the "grey literature" through these searches. For example, the results of Baker et al were published only in abstract form.1 We agree that searching this type of literature is particularly important for finding negative studies, because positive findings are more likely to be published in peer-reviewed journals indexed by MEDLINE. In the case of our pooled analysis, we identified no association between folic acid supplementation and the risk of cardiovascular diseases or all-cause mortality.

We have searched the EMBASE database using identical terms and limits and identified 240 references that were screened; only 1 additional study met our inclusion criteria.2 This study found no difference between the folic acid supplementation group and control group in rate of in-stent restenosis after percutaneous . . . [Full Text of this Article]

Lydia A. Bazzano, MD, PhD
lbazzano@tulane.edu

Kristi Reynolds, PhD
Department of Epidemiology
Tulane University School of Public Health and Tropical Medicine

Kevin N. Holder, MD
Department of Medicine
Tulane University School of Medicine

Jiang He, MD, PhD
Department of Epidemiology
Tulane University School of Public Health and Tropical Medicine
New Orleans, La



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED LETTERS

Folic Acid Supplementation and Cardiovascular Diseases
Suhal S. Mahid, Kyle S. Minor, and Susan Galandiuk
JAMA. 2007;297(14):1549.
EXTRACT | FULL TEXT  

Folic Acid Supplementation and Cardiovascular Diseases
Francesco Dentali, Monica Gianni, and Walter Ageno
JAMA. 2007;297(14):1549-1550.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.